Back To The M&A Rumor Mill: Many Will Recall That Merck Owned These Women's Health Businesses -- After The Bust Up Of Schering Plough... Now To Be Sold, Again?

The saga of what is now Organon. . . travels through Schering-Plough, and then on to US Merck -- and even through various rumors about Sanofi, more recently. As presently constituted, it is a women's health set of franchises -- primarily the implantable version of birth control.

Now come rumors that the massive Indian generics maker, Sun Pharma is quietly circling it. But at this point, these are strictly only. . . rumors.

We do know that as a public '34 Act reporting company (spun out of Merck), Organon will soon have to disclose (at the SEC) -- if it reaches an agreement on price and structure. This is at a size -- a rumored $12 billion, more or less -- that is plainly material. Here's the rumor piece, from Yahoo Biz:

. . .Organon surged by 38.8 percent week-on-week, as investors gobbled up shares following reports that it is set to be acquired by Sun Pharmaceutical Industries for $12 billion.

According to a report by India-based The Economic Times, Sun Pharmaceutical submitted an offer to fully acquire Organon & Co., in an all-cash transaction. The two firms have yet to confirm or deny the reports. . . .

The Dutch HQ-ed version of this biz was always very well run, but faced lots of deeply pocketed competitors. . . and eventually ended up getting sold and resold, by a series of private equity and Wall Street bankers. So it goes.

Onward, to a warm and broken-clouds Sunday, here. Smile.

नमस्ते